0001209191-17-020952.txt : 20170315 0001209191-17-020952.hdr.sgml : 20170315 20170315203748 ACCESSION NUMBER: 0001209191-17-020952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170314 FILED AS OF DATE: 20170315 DATE AS OF CHANGE: 20170315 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack David F CENTRAL INDEX KEY: 0001573072 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 17692700 MAIL ADDRESS: STREET 1: 39 YORKSHIRE DR CITY: OAKLAND STATE: CA ZIP: 94618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-14 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001573072 Novack David F C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710 0 1 0 0 Senior Vice President Common Stock 2017-03-14 4 M 0 20000 0.00 A 22121 D Common Stock 2017-03-14 4 F 0 7947 5.75 D 14174 D Restricted Stock Unit 2017-03-14 4 M 0 20000 D 2024-03-13 Common Stock 20000 0 D Each restricted stock unit represents a right to receive one share of common stock. The reporting person is reporting the withholding by Dynavax Technologies Corporation of 7,947 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 14, 2017. Represents the conversion upon vesting of restricted stock awards into common stock. The reporting person was granted 20,000 restricted stock units on March 11, 2014 which vested on March 14, 2017. Such restricted stock units were previously reported in Table I on a Form 4 filed with the Securities and Exchange Commission on March 13, 2014. David Novack, by /s/ Michael Ostrach, Attorney-in Fact 2017-03-15